Aberdeen Group plc Has $3.29 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Aberdeen Group plc has reduced its holdings in Acadia Healthcare Company, Inc. by 31.0%, selling 48,771 shares, and now owns approximately 0.12% of the company worth $3.29 million.
• Acadia Healthcare reported $0.83 EPS for the quarter, exceeding estimates and showing a 9.2% revenue increase from the previous year, amounting to $869.23 million.
• Despite favorable earnings, several analysts have downgraded their price targets for Acadia Healthcare, with Raymond James lowering theirs from $40.00 to $26.00.

Aberdeen Group plc reduced its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 31.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 108,522 shares of the company's stock after selling 48,771 shares during the quarter. Aberdeen Group plc owned about 0.12% of Acadia Healthcare worth $3,290,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in ACHC. Citigroup Inc. grew its position in shares of Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after purchasing an additional 2,330,898 shares during the last quarter. Madison Avenue Partners LP acquired a new stake in Acadia Healthcare during the fourth quarter worth about $76,339,000. Sachem Head Capital Management LP acquired a new stake in Acadia Healthcare during the fourth quarter worth about $52,734,000. Balyasny Asset Management L.P. acquired a new stake in Acadia Healthcare during the fourth quarter worth about $43,092,000. Finally, Brown Advisory Inc. acquired a new stake in Acadia Healthcare during the first quarter worth about $25,125,000.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded down $0.62 during trading on Tuesday, reaching $21.55. The stock had a trading volume of 1,881,272 shares, compared to its average volume of 2,557,393. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $82.40. The business's 50-day moving average price is $21.95 and its 200 day moving average price is $25.84. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market capitalization of $1.99 billion, a PE ratio of 14.27, a P/E/G ratio of 4.36 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm had revenue of $869.23 million during the quarter, compared to analysts' expectations of $839.59 million. During the same quarter in the previous year, the company posted $0.91 EPS. Acadia Healthcare's revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, equities analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ACHC shares. Barclays decreased their target price on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Raymond James Financial reissued an "outperform" rating and set a $26.00 target price (down from $40.00) on shares of Acadia Healthcare in a research report on Thursday, August 14th. UBS Group cut their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Royal Bank Of Canada cut their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Finally, Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, Acadia Healthcare currently has an average rating of "Moderate Buy" and an average price target of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.